Proteomics and leukocytes: An approach to understanding potential molecular mechanisms of inflammatory responses

Journal of Proteome Research

Volumn 3, Issue 5, 2004, Pages 921-929

  Wang, Xiangdong ^a,c   Zhao, Hong ^b   Andersson, Roland ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NONE   (Sweden)

Author keywords

Human; Inflammation; Leukocytes; Organ injury; Proteans profiles; Proteomics

Indexed keywords

ANNEXIN; CALGRANULIN; CELL ADHESION MOLECULE; CELL PROTEIN; CHITOTRIOSIDASE; GLYCOPROTEIN GP 39; IMMUNOSUPPRESSIVE AGENT; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; RAPAMYCIN; RECEPTOR; UNCLASSIFIED DRUG;

ACCURACY; CELL CULTURE; CELL FUNCTION; CELL INFILTRATION; CELL STIMULATION; DEGRANULATION; DENDRITIC CELL; DISEASE COURSE; DRUG POTENCY; DRUG TARGETING; HUMAN; INFLAMMATION; INFLAMMATORY CELL; LEUKOCYTE; LEUKOCYTE ACTIVATION; LEUKOCYTE FUNCTION; LEUKOCYTE MIGRATION; MACROPHAGE; MEDIATOR RELEASE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION;

DENDRITIC CELLS; ENDOTHELIAL CELLS; EOSINOPHILS; GENE EXPRESSION; HUMANS; INFLAMMATION; LEUKOCYTES; LYMPHOCYTES; MACROPHAGES; MODELS, BIOLOGICAL; MODELS, IMMUNOLOGICAL; MONOCYTES; NEUTROPHILS; PROTEOMICS;

ANIMALIA; PROTEA;

EID: 7044223154     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr0499601     Document Type: Review

References (91)

1. Goris, R. J. MODS/SIRS: result of an overwhelming inflammatory response? World J. Surg. 1996, 20, 418-421.
2. Doig, C. J.; Laupland, K. B.; Zygun, D. A.; Manns, B. J. The epidemiology of severe sepsis syndrome and its treatment with recombinant human activated protein. C. Expert Opin. Pharmacother. 2003, 4, 1789-1799.
3. Wheeler, A. P.; Bernard, G. R. Treating patients with severe sepsis. N. Engl. J. Med. 1999, 340, 207-214.
4. Cavaillon, J. M.; Adib-Conquy, M.; Cloez-Tayarani, I.; Fitting, C. Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review. J. Endotoxin. Res. 2001, 7, 85-93.
5. Seely, A. J.; Pascual, J. L.; Christou, N. V. Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Crit. Care 2003, 7, 291-307.
6. Logan, M. R.; Odemuyiwa, S. O.; Moqbel, R. Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J. Allergy Clin. Immunol. 2003, 111, 923-933.
7. Cooper, D.; Stokes, K. Y.; Tailor, A.; Granger, D. N. Oxidative stress promotes blood cell-endothelial cell interactions in the microcirculation. Cardiovasc. Toxicol. 2002, 2, 165-180.
8. Liew, F. Y. The role of innate cytokines in inflammatory response. Immunol. Lett. 2003, 85, 131-134.
9. Wong, M. M.; Fish, E. N. Chemokines: attractive mediators of the immune response. Semin. Immunol. 2003, 15, 5-14.
10. Figarella-Branger, D.; Civatte, M.; Bartoli, C.; Pellissier, J. F. Cytokines, Chemokines, and cell adhesion molecules in inflammatory myopathies. Muscle Nerve 2003, 28, 659-682.
11. Weber, C. Novel mechanistic concepts for the control of leukocyte transmigration: specialization of integrins, chemokines, and junctional molecules. J. Mol. Med. 2003, 81, 4-19.
12. Laudanna, C.; Kim, J. Y.; Constantin, G.; Butcher, E. Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 2002, 186, 37-46.
13. Luo, X.; Carlson, K. A.; Wojna, V.; Mayo, R.; Biskup, T. M.; Stoner, J.; Anderson, J.; Gendelman, H. E.; Meléndez, L. M. Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment. Neurology 2003, 60, 1931-1937.
14. Aulak, K. S.; Miyagi, M.; Yan, L.; West, K. A.; Massillon, D.; Crabb, J. W.; Stuehr, D. J. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge. Proc. Natl. Acad. Sci. U.S.A. 2001, 90, 12 056-12 061.
15. Nguyen, A.; Yaffe, M. B. Proteomics and systems biology approaches to signal transduction in sepsis. Crit. Care Med. 2003, 31, S1-6.
16. Wagner, J. G.; Roth, R. A. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol. Rev. 2000, 52, 349-374.
17. Yang, J.; Hirata, T.; Croce, K.; Merrill-Skoloff, G.; Tchernychev, B.; Williams, E.; Flaumenhaft, R.; Furie, B. C.; Furie, B. Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J. Exp. Med. 1999, 190, 1769-1782.
18. Zhao, X.; Andersson, R.; Wang, X.; Dib, M.; Wang, X. D. Acute pancreatitis-associated lung injury: pathophysiological mechanisms and potential future therapies. Scand. J. Gastroenterol. 2002, 37, 1351-1358.
19. Rietschel, E. T.; Kirikae, T.; Schade, U. F.; Ulmer, A. J.; Holst, O.; Brade, H., et al. The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiol. 1993, 187, 169-190.
20. Hasday, J. D.; Bascom, R.; Costa, J. J.; Fitzgerald, T.; Dubin, W. Bacterial endotoxin is an active component of cigarette smoke. Chest 1999, 115, 829-835.
21. Bowie, A.; O'Neill, L. A. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J. Leukoc. Biol. 2000, 67, 508-514.
22. Muzio, M.; Polentarutti, N.; Bosisio, D.; Prahladan, M. K.; Mantovani, A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 2000, 67, 450-456.
23. Yang, R. B.; Mark, A. R.; Gray, A.; Huang, A.; Xie, M. H.; Zhang, M.; Goddard, A.; Wood, W. I.; Gurney, A. L.; Godowski, P. J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 1998, 395, 284-288.
24. Fessier, M. B.; Malcolm, K. C.; Duncan, M. W.; Worthen, G. S. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem 2002, 277, 31 291-31 302.
25. Fessler, M. B.; Malcolm, K. C.; Duncan, M. W.; Worthen, G. S. Lipopolysaccharide stimulation of the human neutrophil: an analysis of changes in gene transcription and protein expression by oligonucleotide microarrays and proteomics. Chest 2002; 121: 75S-76S.
26. Dourdin, N.; Bhatt, A. K.; Dutt, P.; Greer, P. A.; Arthur, J. S.; Elce, J. S.; Huttenlocher, A. Reduced cell migration and disruption of the actin cytoskeleton in calpain-deficient embryonic fibroblasts. J. Biol. Chem. 2001, 276, 48 382-48 388.
27. Sengelov, H.; Kjeldsen, L.; Borregaard, N. Control of exocytosis in early neutrophil activation. J. Immunol. 1993, 150, 1535-1543.
28. Boussac, M.; Garin, J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 2000, 21, 665-672.
29. Coxon, P. Y.; Rane, M. J.; Powell, D. W.; Klein, J. B.; McLeish, K. R. Differential mitogen-activated protein kinase stimulation by Fc gamma receptor IIa and Fc gamma receptor IIIb determines the activation phenotype of human neutrophils. J. Immunol. 2000, 164, 6530-6537.
30. Ward, R. A.; Nakamura, M.; McLeish, K. R. Priming of the neutrophil respiratory burst involves p38 mitogen-activated protein kinase-dependent exocytosis of flavocytochrome b558-containing granules. J. Biol. Chem. 2000, 275, 36 713-36 719.
31. Underwood, D. C.; Osborn, R. R.; Bochnowicz, S.; Webb, E. F.; Rieman, D. J.; Lee, J. C.; Romanic, A. M.; Adams, J. L.; Hay, D. W.; Griswold, D. E. SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279, L895-902.
32. Escott, K. J.; Belvisi, M. G.; Birrell, M. A.; Webber, S. E.; Foster, M. L.; Sargent, C. A. Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat. Br. J. Pharmacol. 2000, 131, 173-176.
33. Zu, Y. L.; Ai, Y.; Gilchrist, A.; Labadia, M. E.; Sha'afi, R. I.; Huang, C. K. Activation of MAP kinase-activated protein kinase 2 in human neutrophils after phorbol ester or fMLP peptide stimulation. Blood 1996, 87, 5287-5296.
34. Coxon, P. Y.; Rane, M. J.; Uriarte, S.; Powell, D. W.; Singh, S.; Butt, W.; Chen, Q.; McLeish, K. R. MAPK-activated protein kinase-2 participates in p38 MAPK-dependent and ERK-dependent functions in human neutrophils. Cell Signal 2003, 15, 993-1001.
35. Singh, S.; Powell, D. W.; Rane, M. J.; Millard, T. H.; Trent, J. O. Pierce, W. M.; Klein, J. B.; Machesky, L. M.; McLeish, K. R. Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis. J. Biol. Chem. 2003, 278, 36 410-36 417.
36. Ni, H.; Wang, X. S.; Diener, K.; Yao, Z. MAPKAPK5, a novel mitogen-activated protein kinase (MAPK)-activated protein kinase, is a substrate of the extracellular-regulated kinase (ERK) and p38 kinase. Biochem. Biophys. Res. Commun. 1998, 243, 492-496.
37. Kayyali, U. S.; Pennella, C. M.; Trujillo, C.; Villa, O.; Gaestel, M.; Hassoun, P. M. Cytoskeletal changes in hypoxic pulmonary endothelial cells are dependent on MAPK-activated protein kinase MK2. J. Biol. Chem. 2002, 277, 42 596-42 602.
38. Nabi, I. R. The polarization of the motile cell. J. Cell. Sci. 1999, 112, 1803-1811.
39. Jones, G. E. Cellular signaling in macrophage migration and chemotaxis. J. Leukoc. Biol. 2000, 68, 593-602.
40. Bennett, V.; Baines, A. J. Spectrin and ankyrin-based pathways: metazoan inventions for integrating cells into tissues. Physiol. Rev. 2001, 81, 1353-1392.
41. Nebl, T.; Pestonjamasp, K. N.; Leszyk, J. D.; Crowley, J. L.; Oh, S. W.; Luna, E. J. Proteomic Analysis of a Detergent-resistant Membrane Skeleton from Neutrophil Plasma Membranes. J. Biol. Chem. 2002, 277, 43 399-43 409.
42. Piubelli, C.; Galvani, M.; Hamdan, M.; Domenici, E.; Righetti, P. G. Proteome analysis of rat polymorphonuclear leukocytes: a two-dimensional electrophoresis/mass spectrometry approach. Electrophoresis 2002, 23, 298-310.
43. Lian, Z.; Wang, L.; Yamaga, S.; Bonds, W.; Beazer-Barclay, Y.; Kluger, Y.; Gerstein, M.; Newburger, P. E.; Berliner, N.; Weissman, S. M. Genomic and proteomic analysis of the myeloid differentiation program. Blood 2001, 90, 513-524.
44. Lian, Z.; Kluger, Y.; Greenbaum, D. S.; Tuck, D.; Gerstein, M.; Berliner, N.; Weissman, S. M.; Newburger, P. E. Genomic and proteomic analysis of the myeloid differentiation program: global analysis of gene expression during induced differentiation in the MPRO cell line. Blood 2002, 100, 3209-3220.
45. Banchereau, J., Briere, F.; Caux, C.; Davoust, J.; Lebecque, S.; Liu, Y. J.; Pulendran, B.; Palucka, K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18, 767-811.
46. Young, J. W. Dendritic cells: expansion and differentiation with hematopoietic growth factors. Curr. Opin. Hematol. 1999, 6, 135-144.
47. Le Naour, F.; Hohenkirk, L.; Grolleau, A.; Misek, D. E.; Lescure, P.; Geiger, J. D.; Hanash, S.; Beretta, L. Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics. J. Biol. Chem. 2001, 276, 17 920-17 931.
48. Richards, J.; Le Naour, F.; Hanash, S.; Beretta, L. Integrated genomic and proteomic analysis of signaling pathways in dendritic cell differentiation and maturation. Ann. N.Y. Acad. Sci. 2002, 975, 91-100.
49. Manara, G. C.; Sansoni, P.; Badiali-De Giorgi, L.; Gallinella, G.; Ferrari, C.; Brianti, V.; Fagnoni, F. F.; Ruegg, C. L.; De Panfilis, G.; Pasquinelli, G. New insights suggesting a possible role of a heat shock protein 70-kD family related protein in antigen processing/presentation phenomenon in humans. Blood 1993, 82, 2865-2871.
50. Todryk, S.; Melcher, A. A.; Hardwick, N.; Linardakis, E.; Bateman, A.; Colombo, M. P.; Stoppacciaro, A.; Vile, R. G. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake. J. Immunol. 1999, 163, 1398-1408.
51. Samali, A.; Cotter, T. G. Heat shock proteins increase resistance to apoptosis. Exp. Cell. Res. 1996, 223, 163-170.
52. Geiger, J.; Hutchinson, R.; Hohenkirk, L.; McKenna, E.; Chang, A. Mule J. Treatment of solid tumours in children with tumour-lysate-pulsed dendritic cells. Lancet 2000, 356, 1163-1165.
53. Finkel, T. Redox-dependent signal transduction. FBBS Lett. 2000, 476, 52-54.
54. Salvemini, D.; Cuzzocrea, S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radical Biol. Med. 2002, 33, 1173-1185.
55. Lum, H.; Roebuck, K. A. Oxidant stress and endothelial cell dysfunction. Am. J. Physiol. Cell. Physiol. 2001, 280, C719-C741
56. Seong, J. K.; Kim, do K.; Choi, K. H.; Oh, S. H.; Kim, K. S.; Lee, S. S.; Um, H. D. Proteomic analysis of the cellular proteins induced by adaptive concentrations of hydrogen peroxide in human U937 cells. Exp. Mol. Med. 2002, 34, 374-378.
57. Journet, A.; Chapel, A.; Kieffer, S.; Louwagie, M.; Luche, S.; Garin, J. Towards a human repertoire of monocytic lysosomal proteins. Electrophoresis 2000, 21, 3411-3419.
58. Journet, A.; Chapel, A.; Kieffer, S.; Roux, F.; Garin, J. Proteomic analysis of human lysosomes: application to monocytic and breast cancer cells. Proteomics 2002, 2, 1026-1040.
59. Garin, J., Diez, R., Kieffer, S.; Dermine, J. F.; Duclos, S.; Gagnon, E.; Sadoul, R.; Rondeau, C.; Desjardins, M. The phagosome proteome: insight into phagosome functions. J. Cell. Biol. 2001, 152, 165-180.
60. Yeung, Y. G., Stanley, E. R. Proteomic approaches to the analysis of early events in colony-stimulating factor-1 signal transduction. Mol. Cell. Proteomics 2003, 2, 1143-1155.
61. Juan, H. F.; Lin, J. Y.; Chang, W. H.; Wu, C. Y.; Pan, T. L.; Tseng, M. J.; Khoo, K. H.; Chen, S. T. Biomic study of human myeloid leukemia cells differentiation to macrophages using DNA array, proteomic, and bioinformatic analytical methods. Electrophoresis 2002, 23, 2490-2504.
62. Leimgruber, R. M.; Malone, J. P.; Radabaugh, M. R.; LaPorte, M. L.; Violand, B. N.; Monahan, J. B. Development of improved cell lysis, solubilization and imaging approaches for proteomic analyses. Proteomics 2002, 2, 135-144.
63. Gadgil, H. S.; Pabst, K. M.; Giorgianni, F.; Umstot, E. S.; Desiderio, D. M.; Beranova-Giorgianni, S.; Gerling, I. C.; Pabst, M. J. Proteome of monocytes primed with lipopolysaccharide: analysis of the abundant proteins. Proteomics 2003, 3, 1767-1780.
64. Raftery, M. J.; Yang, Z.; Valenzuela, S. M.; Geczy, C. L. Novel intra-and intermolecular sulfinamide bonds in S100A8 produced by hypochlorite oxidation. J. Biol. Chem. 2001, 276, 33 393-33 401.
65. Ragno, S.; Romano, M.; Howell, S.; Pappin, D. J.; Jenner, P. J.; Colston, M. J. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology 2001, 104, 99-108.
66. Meresse, S.; Steele-Mortimer, O.; Moreno, E.; Desjardins, M.; Finlay, B.; Gorvel, J. P. Controlling the maturation of pathogen-containing vacuoles: a matter of life and death. Nat. Cell. Biol. 1999, 1, 183-188.
67. Mekalanos, J. J. Environmental signals controlling expression of virulence determinants in bacteria. J. Bacteriol. 1992, 174, 1-7.
68. Wang, X. D.; Andersson, R. The role of endothelial cells in the systemic inflammatory response syndrome and multiple system organ failure. Eur. J. Surg. 1995, 161, 703-713.
69. Davies, P. F. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995, 75, 519-560.
70. Pellieux, C.; Desgeorges, A.; Pigeon, C. H.; Chambaz, C.; Yin, H.; Hayoz, D.; Silacci, P.; Cap, G. a gelsolin family protein modulating protective effects of unidirectional shear stress. J. Biol. Chem. 2003, 278, 29 136-29 144.
71. Shi, C. B.; Andersson, R.; Zhao, X.; Wang, X. D. Potential role reactive oxygen speices in pancreatitis-associated multiple organ dysfunction. J Pancreatol. 2004; in press.
72. Wang, X. D.; Deng, X. M.; Haraldsen, P.; Andersson, R.; Ihse, I. Antioxidant and calcium channel blockers counteract endothelial barrier injury induced by acute pancreatitis in rats. Scand. J. Gastroenterol. 1995, 30, 1129-1136.
73. Borrebaeck, C. A.; Carlsson, R. Human therapeutic antibodies. Curr. Opin. Pharmacol. 2001, 1, 404-408.
74. Stone, J. R.; Collins, T. Rapid phosphorylation of heterogeneous nuclear ribonucleoprotein C1/C2 in response to physiologic levels of hydrogen peroxide in human endothelial cells. J. Biol. Chem. 2002, 277, 15 621-15 628.
75. Schlondorff, J.; Blobel, C. P. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J. Cell. Sci. 1999, 112, 3603-3617.
76. Guo, L.; Eisenman, J. R.; Mahimkar, R. M.; Peschon J. J.; Paxton, R. J.; Black, R. A.; Johnson, R. S. A proteomic approach for the identification of cell-surface proteins shed by metalloproteases. Mol. Cell. Proteomics 2002, 1, 30-36.
77. Xu, J.; Qu, D.; Esmon, N. L.; Esmon, C. T. Metalloproteolytic release of endothelial cell protein C receptor. J. Biol. Chem. 2000, 275, 6038-6044.
78. Levi-Schaffer, F.; Temkin, V.; Simon, H. U.; Kettman, J. R., Frey, J. R.; Lefkovits, I. Proteomic analysis of human eosinophil activation mediated by mast cells, granulocyte macrophage colony stimulating factor and tumor necrosis factor alpha. Proteomics 2002, 2, 1616-1626.
79. Lopez, A. F.; Williamson, D. J.; Gamble, J. R.; Begley, C. G.; Harlan, J. M.; Klebanoff, S. J.; Waltersdorph, A.; Wong, G.; Clark S. C.; Vadas, M. A. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Invest. 1986, 78, 1220-1228.
80. Csar, X. F.; Wilson, N. J.; McMahon, K. A.; Marks, D. C.; Beecroft, T. L.; Ward, A. C.; Whitty, G. A.; Kanangasundarum, V.; Hamilton, J. A. Proteomic analysis of macrophage differentiation. p46/52(Shc) Tyrosine phosphorylation is required for CSF-1-mediated macrophage differentiation. J. Biol. Chem. 2001, 276, 26211-26217.
81. El Biaze, M.; Boniface, S.; Koscher, V.; Mamessier, E.; Dupuy, P.; Milhe, F.; Ramadour, M.; Vervloet, D.; Magnan, A. T cell activation, from atopy to asthma: more a paradox than a paradigm. Allergy 2003, 50, 844-853.
82. Wood, J. J.; Rodrick, M. L.; O'Mahony, J. B.; Palder S. B.,; Saporoschetz, I.' D'Eon, P.; Mannick, J. A. Inadequate interleukin 2 production. A fundamental immunological deficiency in patients with major burns. Ann. Surg. 1984, 200, 311-320.
83. Shiio, Y.; Eisenman, R. N.; Yi, E. C.; Donohoe, S.; Goodlett, D. R.; Aebersold, R. Quantitative proteomic analysis of chromatin-associated factors. J. Am. Soc. Mass Spectrom. 2003, 14, 696-703.
84. Truffa-Bachi, P.; Lefkovits, I.; Frey, J. R. Proteomic analysis of T cell activation in the presence of cyclosporin A: immunosuppressor and activator removal induces de novo protein synthesis. Mol. Immunol. 2000, 37, 21-28.
85. Mascarell, L.; Frey, J. R.; Michel, F.; Lefkovits, I.; Truffa-Bachi, P. Increased protein synthesis after T cell activation in the presence of cyclosporin A. Transplantation 2000, 70, 340-348.
86. Joubert-Caron, R.; Le Caer, J. P.; Montandon, F.; Poirier, F.; Pontet, M.; Imam, N.; Feuillard, J.; Bladier, D.; Rossier, J.; Caron, M. Protein analysis by mass spectrometry and sequence database searching: A proteomic approach to identify human lymphoblastoid cell line proteins. Electrophresis 2000, 21, 2566-2575.
87. Vuadens, F.; Gasparini, D.; Deon, C.; Sanchez, J. C.; Hochstrasser, D. F.; Schneider, P.; Tissot, J. D. Identification of specific proteins in different lymphocyte populations by proteomic tools. Proteomics 2001, 2, 105-111.
88. Grolleau, A.; Bowman, J.; Pradet-Balade, B.; Puravs, E.; Hanash, S.; Garcia-Sanz, J. A.; Beretta, L. Global and specific transtional control by rapamycin in T cells uncovered by microarrays and proteomics. J. Biol. Chem. 2002, 277, 22 175-22 184.
89. Nollau, P.; Mayer, B. J. Profiling the global tyrosine phosphorylation state by Src homology 2 domain binding. PNAS 2001, 98, 13531-13536.
90. Komai, M.; Tanaka, H.; Masuda, T.; Nagao, K.; Ishizaki, M.; Sawada, M.; Nagai, H. Role of Th2 responses in the development of allergen-induced airway remodelling in a murine model of allergic asthma. Br. J. Pharmacol. 2003, 138, 912-920.
91. Stancato, L. F.; Petricoin, E. F., III Fingerprinting of signal transduction pathways using a combination of anti-phosphotyrosine immunoprecipitations and two-dimensional polycrylamide gel electrophoresis. Electrophoresis 2001, 22, 2120-2124.